CSF1R and liver disorder: In one study of Safer and Faster Evidence-based Translation (SAFE-T), patients under flupirtine treatment showed increased MCSFR levels in comparison to APAP-induced hepatotoxicity cases, suggesting that high serum/plasma levels of MCSFR may have value as a prognostic marker for liver disease associated with inflammation and immune system activation [32,267].